[An analysis of the causes for the occurrence of Down's syndrome and the current approaches to its prevention at the stage of mass prenatal ultrasonic and immunobiochemical screening of pregnant women].
Problems of prenatal complex diagnosis of Down's syndrome are considered. The levels of alpha-fetoprotein in blood serum of pregnant women should be studied in the optimum terms (17-19 weeks of pregnancy). The assessment of several immuno-biochemical markers is most important for diagnosis.
['Down Syndrome/diagnostic imaging/*etiology/*prevention & control', 'Female', 'Humans', 'Karyotyping', 'Mass Screening/*methods', 'Maternal Age', 'Pregnancy', '*Ultrasonography, Prenatal']